Cargando…

G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy

BACKGROUND: Evidence-based guidelines concerning the older head and neck cancer (HNCA) patient are lacking. Accurate patient selection for optimal care management is therefore challenging. We examined if geriatric assessment is indicative of long-term health-related quality of life (HRQOL) and overa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pottel, Lies, Lycke, Michelle, Boterberg, Tom, Pottel, Hans, Goethals, Laurence, Duprez, Fréderic, Rottey, Sylvie, Lievens, Yolande, Van Den Noortgate, Nele, Geldhof, Kurt, Buyse, Véronique, Kargar-Samani, Khalil, Ghekiere, Véronique, Debruyne, Philip R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640221/
https://www.ncbi.nlm.nih.gov/pubmed/26553007
http://dx.doi.org/10.1186/s12885-015-1800-1
_version_ 1782400049729241088
author Pottel, Lies
Lycke, Michelle
Boterberg, Tom
Pottel, Hans
Goethals, Laurence
Duprez, Fréderic
Rottey, Sylvie
Lievens, Yolande
Van Den Noortgate, Nele
Geldhof, Kurt
Buyse, Véronique
Kargar-Samani, Khalil
Ghekiere, Véronique
Debruyne, Philip R.
author_facet Pottel, Lies
Lycke, Michelle
Boterberg, Tom
Pottel, Hans
Goethals, Laurence
Duprez, Fréderic
Rottey, Sylvie
Lievens, Yolande
Van Den Noortgate, Nele
Geldhof, Kurt
Buyse, Véronique
Kargar-Samani, Khalil
Ghekiere, Véronique
Debruyne, Philip R.
author_sort Pottel, Lies
collection PubMed
description BACKGROUND: Evidence-based guidelines concerning the older head and neck cancer (HNCA) patient are lacking. Accurate patient selection for optimal care management is therefore challenging. We examined if geriatric assessment is indicative of long-term health-related quality of life (HRQOL) and overall survival in this unique population. METHODS: All HNCA patients, aged ≥65 years, eligible for curative radio(chemo)therapy were evaluated with the Geriatric-8 (G-8) questionnaire and a comprehensive geriatric assessment (CGA). Euroqol-5 dimensions (EQ-5D) and survival were collected until 36 months post treatment start. Repeated measures ANOVA was applied to analyse HRQOL evolution in ‘fit’ and ‘vulnerable’ patients, defined by G-8. Kaplan-Meier curves and cox proportional hazard analysis were established for determination of the prognostic value of geriatric assessments. Quality-adjusted survival was calculated in both patient subgroups. RESULTS: One hundred patients were recruited. Seventy-two percent of patients were considered vulnerable according to CGA (≥2 abnormal tests). Fit patients maintained a relatively acceptable long-term HRQOL, whilst vulnerable patients showed significantly lower median health states. The difference remained apparent at 36 months. Vulnerability, as classified by G-8 or CGA, came forward as independent predictor for lower EQ-5D index scores. After consideration of confounders, a significantly lower survival was observed in patients defined vulnerable according to G-8, compared to fit patients. A similar trend was seen based on CGA. Calculation of quality-adjusted survival showed significantly less remaining life months in perfect health in vulnerable patients, compared to fit ones. CONCLUSIONS: G-8 is indicative of quality-adjusted survival, and should be considered at time of treatment decisions for the older HNCA patient. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1800-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4640221
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46402212015-11-11 G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy Pottel, Lies Lycke, Michelle Boterberg, Tom Pottel, Hans Goethals, Laurence Duprez, Fréderic Rottey, Sylvie Lievens, Yolande Van Den Noortgate, Nele Geldhof, Kurt Buyse, Véronique Kargar-Samani, Khalil Ghekiere, Véronique Debruyne, Philip R. BMC Cancer Research Article BACKGROUND: Evidence-based guidelines concerning the older head and neck cancer (HNCA) patient are lacking. Accurate patient selection for optimal care management is therefore challenging. We examined if geriatric assessment is indicative of long-term health-related quality of life (HRQOL) and overall survival in this unique population. METHODS: All HNCA patients, aged ≥65 years, eligible for curative radio(chemo)therapy were evaluated with the Geriatric-8 (G-8) questionnaire and a comprehensive geriatric assessment (CGA). Euroqol-5 dimensions (EQ-5D) and survival were collected until 36 months post treatment start. Repeated measures ANOVA was applied to analyse HRQOL evolution in ‘fit’ and ‘vulnerable’ patients, defined by G-8. Kaplan-Meier curves and cox proportional hazard analysis were established for determination of the prognostic value of geriatric assessments. Quality-adjusted survival was calculated in both patient subgroups. RESULTS: One hundred patients were recruited. Seventy-two percent of patients were considered vulnerable according to CGA (≥2 abnormal tests). Fit patients maintained a relatively acceptable long-term HRQOL, whilst vulnerable patients showed significantly lower median health states. The difference remained apparent at 36 months. Vulnerability, as classified by G-8 or CGA, came forward as independent predictor for lower EQ-5D index scores. After consideration of confounders, a significantly lower survival was observed in patients defined vulnerable according to G-8, compared to fit patients. A similar trend was seen based on CGA. Calculation of quality-adjusted survival showed significantly less remaining life months in perfect health in vulnerable patients, compared to fit ones. CONCLUSIONS: G-8 is indicative of quality-adjusted survival, and should be considered at time of treatment decisions for the older HNCA patient. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1800-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-09 /pmc/articles/PMC4640221/ /pubmed/26553007 http://dx.doi.org/10.1186/s12885-015-1800-1 Text en © Pottel et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pottel, Lies
Lycke, Michelle
Boterberg, Tom
Pottel, Hans
Goethals, Laurence
Duprez, Fréderic
Rottey, Sylvie
Lievens, Yolande
Van Den Noortgate, Nele
Geldhof, Kurt
Buyse, Véronique
Kargar-Samani, Khalil
Ghekiere, Véronique
Debruyne, Philip R.
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title_full G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title_fullStr G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title_full_unstemmed G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title_short G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
title_sort g-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640221/
https://www.ncbi.nlm.nih.gov/pubmed/26553007
http://dx.doi.org/10.1186/s12885-015-1800-1
work_keys_str_mv AT pottellies g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT lyckemichelle g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT boterbergtom g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT pottelhans g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT goethalslaurence g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT duprezfrederic g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT rotteysylvie g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT lievensyolande g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT vandennoortgatenele g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT geldhofkurt g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT buyseveronique g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT kargarsamanikhalil g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT ghekiereveronique g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy
AT debruynephilipr g8indicatesoverallandqualityadjustedsurvivalinolderheadandneckcancerpatientstreatedwithcurativeradiochemotherapy